Press Releases

NEW YORK, Sept. 12, 2019 /PRNewswire/ -- Contraceptive App Natural Cycles and UCL release new study revealing that, contrary to popular belief, menstrual cycles are considerably varied with only 13% of women having cycles that last 28 days.The study published in 

SCOTTSDALE, Ariz., Sept. 12, 2019 /PRNewswire/ -- Today Massage Envy, the nation's #1 provider of massage and skin care services, announced a breakthrough new acne series to be rolled out nation

LAS VEGAS, Sept. 12, 2019 /PRNewswire/ -- JanOne, Inc. (NASDAQ: JAN), a newly launched initiative with the focused intent of offering innovative, actionable solutions to end the opioid crisis, is proud to name host of America This Week and financial commentator Eric Bolling as its President and Chairman.

YARDLEY, Pa., Sept. 12, 2019 /PRNewswire/ -- A new research study authored by StayWell shows a direct association between participation in workplace health and well-being programs and employee health status. The study is the first of its kind to quantify and examine the impact of program participation across multiple program components through the creation of a par

SECAUCUS, N.J. and INDIANAPOLIS, Sept. 12, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information s

LEXINGTON, Mass., Sept. 12, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the promotion of Bill Steinkrauss to Chief Financial Officer. Mr. Steinkrauss joined Curis in August 2016 and m

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 12, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX), a leader in personalized cannabis based cancer medicine, today announced that its Scientific Director, Dr.

LA JOLLA, Calif., Sept. 12, 2019 /PRNewswire/ -- Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), today announced that Arthur A. Levin, Ph.D., Chief Scientific Officer, is scheduled to present at the 2019 Myotonic Annual Conference on Satur

LA JOLLA, Calif., Sept. 12, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of i

SAN DIEGO, Sept. 12, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the formation of its Scientific Advisory Board (SAB), which is comprised of industry experts in inflammatory and dermatological disease drug development.  The SAB